
Twist Bioscience Corporation TWST
$ 31.33
1.29%
Annual report 2025
added 11-17-2025
Country |
|
IPO year |
2018 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
59.8 M |
Market Cap[1] |
$ 1.87 B |
EBITDA (LTM) |
$ -170 M |
P/E (LTM) |
-13.34 |
P/S (LTM) |
5.15 |
EPS (LTM) |
-2.32 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Brainsway Ltd.
BWAY
|
$ 17.27 | 1.8 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 15.82 | 0.44 % | $ 170 M | Nasdaq Global Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
BioNano Genomics
BNGO
|
$ 1.55 | -4.63 % | $ 1.97 M | Nasdaq Capital Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
DarioHealth Corp.
DRIO
|
$ 12.14 | 2.1 % | $ 344 M | Nasdaq Capital Market | ||
|
DexCom
DXCM
|
$ 65.83 | -1.69 % | $ 25.4 B | Nasdaq Global Select Market,SPB | ||
|
Castle Biosciences
CSTL
|
$ 39.06 | 1.11 % | $ 1.08 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 101.64 | 0.14 % | $ 18.8 B | Nasdaq Capital Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 227.72 | 0.54 % | $ 166 B | NYSE,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 27.0 | -0.52 % | $ 816 M | Nasdaq Global Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 19.98 | -2.82 % | $ 1.07 B | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 101.67 | -3.4 % | $ 4.01 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Anixa Biosciences
ANIX
|
$ 3.3 | -7.82 % | $ 105 K | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 0.29 | -14.47 % | $ 8.51 M | Nasdaq Capital Market | ||
|
IQVIA Holdings
IQV
|
$ 222.75 | 0.24 % | $ 40.4 B | NYSE,SPB | ||
|
Guardant Health
GH
|
$ 103.7 | 1.6 % | $ 12.7 B | Nasdaq Global Select Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 134.4 | -0.35 % | $ 21.4 B | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 197.62 | 2.4 % | $ 10.2 B | NYSE,SPB | ||
|
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | ||
|
Mettler-Toledo International
MTD
|
$ 1 410.02 | 1.15 % | $ 29.9 B | NYSE,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 183.96 | 0.79 % | $ 20.4 B | NYSE,SPB | ||
|
NeoGenomics
NEO
|
$ 12.03 | 1.48 % | $ 1.52 B | Nasdaq Global Select Market,SPB | ||
|
Neogen Corporation
NEOG
|
$ 6.85 | -0.22 % | $ 1.49 B | Nasdaq Global Select Market,SPB | ||
|
Biodesix
BDSX
|
$ 7.63 | -2.8 % | $ 989 M | Nasdaq Global Market | ||
|
Myriad Genetics
MYGN
|
$ 7.04 | -2.36 % | $ 638 M | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 262.89 | -0.48 % | $ 22.1 B | NYSE,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 184.38 | -1.18 % | $ 15.2 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 698.77 | -0.77 % | $ 57.6 B | Nasdaq Global Select Market,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 66.4 | -0.33 % | $ 4.59 B | Nasdaq Global Select Market,SPB | ||
|
Agilent Technologies
A
|
$ 140.3 | 0.46 % | $ 42.7 B | NYSE,SPB | ||
|
Biomerica
BMRA
|
$ 2.48 | -2.65 % | $ 5.7 M | Nasdaq Capital Market | ||
|
Bioventus
BVS
|
$ 7.49 | -0.86 % | $ 469 M | Nasdaq Global Select Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Pacific Biosciences of California
PACB
|
$ 2.13 | 0.24 % | $ 540 M | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.